RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Nazarius S. Lamango to Carcinoma, Non-Small-Cell Lung

Back to Details
This is a "connection" page, showing publications Nazarius S. Lamango has written about Carcinoma, Non-Small-Cell Lung.
Nazarius S. Lamango
Connection Strength
0.536
Carcinoma, Non-Small-Cell Lung
  1. Ntantie E, Fletcher J, Amissah F, Salako OO, Nkembo AT, Poku RA, Ikpatt FO, Lamango NS. Polyisoprenylated cysteinyl amide inhibitors disrupt actin cytoskeleton organization, induce cell rounding and block migration of non-small cell lung cancer. Oncotarget. 2017 May 09; 8(19):31726-31744.
    View in: PubMed
    Score: 0.536
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support